Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine

By Nirmal S.   Cherian T.   Samuel B.U.   Rajasingh J.   Raghupathy P.   John T.J.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 928-931

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a pilot inactivated poliovirus vaccine with trypsin-treated type 3-component

By Piirainen L.   Roivainen M.   Litmanen L.   Eskola J.   Beuvery E.C.   Hovi T.  

Vaccine, Vol. 15, Iss. 2, 1997-02 ,pp. : 237-243

Elsevier

Access to resources Recommend Favorite

Maternal immunization with inactivated influenza vaccine: rationale and experience

By Englund J.A.  

Vaccine, Vol. 21, Iss. 24, 2003-07 ,pp. : 3460-3464

Elsevier

Access to resources Recommend Favorite

Randomised, controlled trial with the trypsin-modified inactivated poliovirus vaccine: assessment of intestinal immunity with live challenge virus

By Piirainen L.   Stenvik M.   Roivainen M.   Eskola J.   Beuvery E.C.   Hovi T.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1084-1090

Elsevier

Access to resources Recommend Favorite

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience

By Pittman P.R.   Liu C.T.   Cannon T.L.   Makuch R.S.   Mangiafico J.A.   Gibbs P.H.   Peters C.J.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 181-189

Elsevier

Access to resources Recommend Favorite